Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CPH/HLUN.B stock hub

CPH/HLUN.B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CPH/HLUN.Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

41.1B

Copenhagen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CPH/HLUN.B

In the news

Latest news · CPH/HLUN.B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7

P25 14.6P50 19.5P75 24.2

Trailing P/E13.4

P25 11.8P50 20.8P75 32.9

ROE12.8

P25 -4.6P50 11.3P75 24.2

ROIC12.5

P25 -8.1P50 8.5P75 13.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CPH/HLUN.B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

DKK

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DK
Employees	5,039
Employees Change	-404%
Employees Change Percent	-7.42
Enterprise value	DKK 49.3B
Exchange	Copenhagen Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	DK0061804770
Last refreshed	2026-05-10
Market cap	DKK 41.1B
Price	DKK 43.06
Price currency	DKK
Rev Per Employee	4,887,874.58x
Sector	Healthcare
Sic	2834
Symbol	cph/HLUN.B
Website	https://www.lundbeck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.76%
EV Earnings	15.46x
EV/EBIT	8.39x
EV/EBITDA	6.37x
EV/FCF	10.01x
EV/Sales	2x
FCF yield	11.98%
Forward P/E	6.96x
P/B ratio	1.65x
P/E ratio	13.38x
P/S ratio	1.67x
PE Ratio3 Y	12.9x
PE Ratio5 Y	14.04x
PEG ratio	87.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.88%
EBITDA Margin	31.08%
FCF margin	20%
Gross margin	82.68%
Gross Profit	DKK 20.4B
Gross Profit Growth	14.58%
Gross Profit Growth Q	8.48%
Gross Profit Growth3 Y	12.52%
Gross Profit Growth5 Y	8.49%
Net Income	DKK 3.2B
Net Income Growth	1.56%
Net Income Growth Years	4%
Net Income Growth3 Y	18.55%
Net Income Growth5 Y	15.09%
Pretax Margin	18.22%
Profit Margin	12.96%
Profit Per Employee	DKK 633,459
Profitable Years	10
ROA	6.7
Roa5y	5.44
ROCE	13.62
ROE	12.79
Roe5y	10.83
ROIC	12.45
Roic5y	11.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	43.37%
Cagr3y	10.3%
Div CAGR3	18%
EPS Growth	1.5
EPS Growth Years	4
EPS Growth3 Y	18.58
EPS Growth5 Y	15.12
FCF Growth	74.84%
FCF Growth3 Y	16.1%
FCF Growth5 Y	7.24%
OCF Growth	64.79%
OCF Growth10 Y	39.46%
OCF Growth3 Y	15.92%
OCF Growth5 Y	7.39%
Revenue Growth	11.93x
Revenue Growth Q	9.96x
Revenue Growth Quarters	16x
Revenue Growth Years	4x
Revenue Growth3 Y	10.52x
Revenue Growth5 Y	6.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 0.45
Assets	DKK 52.1B
Cash	DKK 3.4B
Current Assets	DKK 12.8B
Current Liabilities	DKK 8.9B
Debt	DKK 11.7B
Debt EBITDA	DKK 1.5
Debt Equity	DKK 0.47
Debt FCF	DKK 2.37
Equity	DKK 24.9B
Interest Coverage	11.44
Liabilities	DKK 27.2B
Long Term Assets	DKK 39.3B
Long Term Liabilities	DKK 18.3B
Net Cash	DKK -8.2B
Net Cash By Market Cap	DKK -19.99
Net Debt EBITDA	DKK 1.07
Net Debt Equity	DKK 0.33
Net Debt FCF	DKK 1.67
Tangible Book Value	DKK -10.9B
Tangible Book Value Per Share	DKK -10.97
WACC	5.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.44
Inventory Turnover	1.01
Net Working Capital	DKK 571M
Quick ratio	0.9
Working Capital	DKK 3.9B
Working Capital Turnover	DKK 5.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.06%
Dividend Growth	21.05%
Dividend Growth Years	3%
Dividend per share	DKK 1.15
Dividend Years	4
Dividend Yield	2.67%
Ex Div Date	2026-03-19
Last Dividend	DKK 1.15
Payout Frequency	Annual
Payout Ratio	29.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	43.33%
200-day SMA	41.84
3Y total return	34.19%
50-day SMA	40.11
50-day SMA vs 200-day SMA	50under200
All Time High	49.38
All Time High Change	-12.8%
All Time High Date	2024-10-17
All Time Low	23.3
All Time Low Change	84.85%
All Time Low Date	2022-10-03
ATR	1.02
Beta	0.26
Beta1y	0.58
Beta2y	0.77
Ch YTD	-0.23
High	43.26
High52	47.78
High52 Date	2025-10-31
High52ch	-9.88%
Low	42.28
Low52	29
Low52 Date	2025-05-12
Low52ch	48.48%
Ma50ch	7.35%
Price vs 200-day SMA	2.93%
RSI	59.02
RSI Monthly	54.68
RSI Weekly	54.68
Sharpe ratio	1.08x
Sortino ratio	1.81
Total Return	2.61%
Tr YTD	2.88
Tr1m	8.46%
Tr1w	1.56%
Tr3m	18.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 5.9B
Operating Income Growth	38.82
Operating Income Growth Q	-17.92
Operating Income Growth3 Y	27.29
Operating Income Growth5 Y	15.29
Operating margin	23.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	304,661,102%
Net Borrowing	-5,099,000,000
Shares Insiders	0.15%
Shares Institutions	10.25%
Shares Out	991,227,477
Shares Qo Q	0.04%
Shares Yo Y	0.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK 4.9B
Average Volume	586,141.55x
Bv Per Share	25.12
CAPEX	DKK -554M
Ch1m	8.46
Ch1w	1.56
Ch1y	38.99
Ch3m	14.95
Ch3y	24.24
Ch6m	-5.24
Change	0.19%
Change From Open	0.56
Close	42.98
Days Gap	-0.37
Depreciation Amortization	1,773,000,000
Dollar Volume	18,879,527.8
Earnings Date	2026-05-13
EBIT	DKK 5.9B
EBITDA	DKK 7.7B
EPS	DKK 3.22
F Score	6
FCF	DKK 4.9B
FCF EV Yield	9.99x
FCF Per Share	DKK 4.97
Financing CF	-6,062,000,000
Fiscal Year End	December
Founded	1,915
Goodwill	7,008,000,000
Graham Number	44.28664
Graham Upside	2.85
Income Tax	DKK 1.3B
Investing CF	-611,000,000
Is Primary Listing	1
Last Earnings Date	2026-02-04
Last Report Date	2025-12-31
Lynch Fair Value	DKK 50.43
Lynch Upside	17.12
Ma150	42.59
Ma150ch	1.12%
Ma20	42.53
Ma20ch	1.25%
Net CF	-1,231,000,000
Next Earnings Date	2026-05-13
Open	42.82
P FCF Ratio	8.35
P OCF Ratio	7.5
Payment Date	2026-03-23
Position In Range	79.59
Ppne	1,833,000,000
Price Date	2026-05-08
Price EBITDA	DKK 5.37
Relative Volume	0.75x
Revenue	24,630,000,000x
Tax By Revenue	5.26x
Tax Rate	28.86%
Tr6m	-2.28%
Volume	438,447
Z Score	2.43

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

CPH/HLUN.B dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$1.15 annual per share

Payout ratio

+29.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+2.6%

Next ex-dividend date: 2026-03-19

Performance

CPH/HLUN.B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CPH/HLUN.B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.2%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

CPH/HLUN.B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.0

Neutral momentum band

Price vs 200-day MA

+2.9%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

1.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CPH/HLUN.B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cph/HLUN.B stock rating?

cph/HLUN.B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cph/HLUN.B analysis?

The full report lives at /stocks/cph/HLUN.B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cph/HLUN.B?

The latest report frames cph/HLUN.B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cph/HLUN.B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.